BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24445478)

  • 1. T cell subsets and their role in the pathogenesis of rheumatic disease.
    Gizinski AM; Fox DA
    Curr Opin Rheumatol; 2014 Mar; 26(2):204-10. PubMed ID: 24445478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection and rheumatic diseases: a review (2).
    Vaughan JH
    Bull Rheum Dis; 1990; 39(2):1-8. PubMed ID: 2190662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lung and autoimmune disease--therapy].
    Hauber HP; Zabel P
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic treatments for systemic rheumatic diseases.
    Shirota Y; Illei GG; Nikolov NP
    Oral Dis; 2008 Apr; 14(3):206-16. PubMed ID: 18282173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome.
    Mavragani CP; Nezos A; Moutsopoulos HM
    Curr Opin Rheumatol; 2013 Sep; 25(5):623-9. PubMed ID: 23846338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma-exchange in the treatment of systemic rheumatic diseases: past and present experience].
    Cozzi F; Marson P
    Reumatismo; 2009; 61(3):161-4. PubMed ID: 19888500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.
    Muraoka S; Nishio J; Kuboi Y; Imai T; Nanki T
    Expert Opin Biol Ther; 2020 Nov; 20(11):1309-1319. PubMed ID: 32401060
    [No Abstract]   [Full Text] [Related]  

  • 11. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatic manifestations of malignancy.
    Conaghan PG; Brooks PM
    Curr Opin Rheumatol; 1994 Jan; 6(1):105-10. PubMed ID: 8031673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?
    Wenink MH; Leijten EFA; Cupedo T; Radstake TRDJ
    Arthritis Rheumatol; 2017 May; 69(5):885-897. PubMed ID: 28217945
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis with subsequent development of rheumatoid arthritis, Sjögren's syndrome, and rheumatoid vasculitis.
    Clayman MD; Reinertsen JL
    Arthritis Rheum; 1978 Apr; 21(3):383-9. PubMed ID: 646836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunology of rheumatoid diseases.
    Koffler D
    Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.
    Miao J; Zhu P
    Curr Rheumatol Rep; 2018 Apr; 20(5):30. PubMed ID: 29663162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell depletion therapy in rheumatic disease.
    Edwards JC; Cambridge G; Leandro MJ
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural biological models of autoimmune diseases].
    Pleskovskaia GN
    Revmatologiia (Mosk); 1991; (4):38-44. PubMed ID: 1805332
    [No Abstract]   [Full Text] [Related]  

  • 20. Costimulation blockade in rheumatic diseases: where we are?
    Goëb V; Buch MH; Vital EM; Emery P
    Curr Opin Rheumatol; 2009 May; 21(3):244-50. PubMed ID: 19342956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.